08:52am Saturday 28 March 2020

Motor Neuron Disease gene pinpointed

Brain scan - web

The investigators studied a large group of Finnish patients and a family from Gwent who have lost many relatives to early onset motor neuron disease (MND) and the neurodegenerative disease fronto-temporal dementia, also known as Pick’s disease. The team, including scientists from the School of Medicine, discovered that both the Gwent family and the Finnish patients share a changed genetic segment on the short arm of chromosome 9.

Five thousand people in the UK have MND, and well known sufferers have included David Niven and Don Revie. The disease has recently been diagnosed in the South African rugby player Joost van der Westhuizen. The disease is progressive and fatal, with an average survival from onset of symptoms between two and five years.

Motor neuron scientists have been studying chromosome 9 for some years but until now have not been able to pinpoint the gene that causes the disease. The new discovery identifies the critical gene change as an expanded sequence of DNA repeats. Unaffected people carry up to 20 DNA repeats in a gene called C9orf72 whereas affected patients with motor neuron disease may carry hundreds of repeats. The gene change affects a gene segment outside of the normal protein coding portion of the gene (affecting non-coding RNA).

The role of this DNA expansion is currently unknown but it probably disrupts multiple mechanisms in motor nerve cells (motor neurons), leading to their premature failure and motor neuron cell death. The new discovery will lead to new blood tests for families with a history of this condition, and, potentially, to new avenues for treating the incurable disease.

The genetic variation was difficult to identify because it lies outside the protein coding regions that are normally studied in human genetic work. Although this variation was identified first in Finnish and Welsh patients it appears to occur in many different populations and accounts for the disease in up to one third of patients with a family history of motor neuron disease.

The Motor Neurone Disease Association and the ALS (Amyotrophic Lateral Sclerosis) Association funded the study, together with the Medical Research Council and the Wellcome Trust.

Dr Huw Morris, based at the MRC Centre for Neuropsychiatric Genetics, School of Medicine and the Royal Gwent Hospital, said: “This work is the culmination of many years work by doctors and scientists studying this condition and it is due in large part to the courage and tenacity of many patients facing motor neuron disease, particularly the Gwent kindred and the Finnish cohort. Although this work is the end of our long hunt for this gene, it is the beginning of our search for therapies based on this discovery that can stop this brutal disease in its tracks.”

The international collaboration was led by Bryan Traynor of the National Institutes of Health in the USA with colleagues from Cardiff University, UCL, The University of Manchester, Amsterdam and Finland. Their findings have just been published in the leading international journal Neuron. The same finding was independently made by a group at Mayo Clinic, Jacksonville, Florida, led by Dr Rosa Rademakers and published in the same journal.

Dr Brian Dickie, director of research development at the Motor Neurone Disease Association, said: “Discoveries in genetics are driving the ever-increasing momentum of motor neuron disease research. Chromosome 9 has been a prime suspect in motor neuron disease for some time but pinning down the precise genetic factor involved had proved elusive. The discovery of this rogue gene has the potential to significantly advance our understanding of motor neuron disease, helping scientists to home in on the pivotal cellular changes underlying all forms of the disease.”

Share on:

MORE FROM Brain and Nerves

Health news